Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Matosevic

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Molecular Biosciences|August 10, 2019
Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid TumorsAndrea M Chambers, Sandro Matosevic
Cancer Gene Therapy|October 27, 2025
Defining treatment-resistant brain cancer: Genetic screening to identify oncogene-driven immunomodulation and therapy resistanceZachary David Myers, Sandro Matosevic
Journal of the American Chemical Society|February 12, 2011
Stepwise synthesis of giant unilamellar vesicles on a microfluidic assembly lineSandro Matosevic, Brian M Paegel
Immunology Letters|October 3, 2017
Natural killer-92 cells maintain cytotoxic activity after long-term cryopreservation in novel DMSO-free mediaShannon Pasley, Claudia Zylberberg, Sandro Matosevic
Med (New York, N.Y.)|February 12, 2026
Toward precision immunotherapy: In vivo gene editing of T, NK, and myeloid cellsKhanh Ha Nguyen, Soumyajit Das, Sandro Matosevic
Frontiers in Immunology|November 24, 2018
Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer CellsAndrea M Chambers, Kyle B Lupo, Sandro Matosevic
Biochemical Pharmacology|October 9, 2025
The differential regulation of the urea cycle in tumors goes awryAhmed M Abou-Shanab, Mennatallah A Khedr, Sandro Matosevic
Journal for Immunotherapy of Cancer|December 6, 2018
Purinergic targeting enhances immunotherapy of CD73<sup>+</sup> solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cellsJiao Wang, Kyle B Lupo, Andrea M Chambers, et al.
Cancers|August 30, 2020
TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with ActivationTram N Dao, Sagar Utturkar, Nadia Atallah Lanman, et al.
Cytotherapy|July 17, 2021
Differentiation of natural killer cells from induced pluripotent stem cells under defined, serum- and feeder-free conditionsKyle B Lupo, Jung-Il Moon, Andrea M Chambers, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Molecular Biosciences|August 10, 2019
Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid TumorsAndrea M Chambers, Sandro Matosevic
Cancer Gene Therapy|October 27, 2025
Defining treatment-resistant brain cancer: Genetic screening to identify oncogene-driven immunomodulation and therapy resistanceZachary David Myers, Sandro Matosevic
Journal of the American Chemical Society|February 12, 2011
Stepwise synthesis of giant unilamellar vesicles on a microfluidic assembly lineSandro Matosevic, Brian M Paegel
Immunology Letters|October 3, 2017
Natural killer-92 cells maintain cytotoxic activity after long-term cryopreservation in novel DMSO-free mediaShannon Pasley, Claudia Zylberberg, Sandro Matosevic
Med (New York, N.Y.)|February 12, 2026
Toward precision immunotherapy: In vivo gene editing of T, NK, and myeloid cellsKhanh Ha Nguyen, Soumyajit Das, Sandro Matosevic
Frontiers in Immunology|November 24, 2018
Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer CellsAndrea M Chambers, Kyle B Lupo, Sandro Matosevic
Biochemical Pharmacology|October 9, 2025
The differential regulation of the urea cycle in tumors goes awryAhmed M Abou-Shanab, Mennatallah A Khedr, Sandro Matosevic
Journal for Immunotherapy of Cancer|December 6, 2018
Purinergic targeting enhances immunotherapy of CD73<sup>+</sup> solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cellsJiao Wang, Kyle B Lupo, Andrea M Chambers, et al.
Cancers|August 30, 2020
TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with ActivationTram N Dao, Sagar Utturkar, Nadia Atallah Lanman, et al.
Cytotherapy|July 17, 2021
Differentiation of natural killer cells from induced pluripotent stem cells under defined, serum- and feeder-free conditionsKyle B Lupo, Jung-Il Moon, Andrea M Chambers, et al.
Pageof 5